Skip to main content

Biotech ETFs Break Out

The rally in biotechnology exchange traded funds is going vertical in early 2012 with the sector’s largest ETF posting a gain of 20% over the past three months. The $1.5 billion iShares Nasdaq Biotechnology Index Fund (IBB) is breaking out to new all-time highs. The ETF is up 9.6% year to...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.